The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 20%. Our forward projection puts the odds of a 10% gain over the next month near 8%. The street (15 analysts) rates it hold, with a mean price target of $114.
Kimberly-Clark KMB
Clears the common standard
An entry written while the outcome is still unknown. It will be scored by what the market does next, and it will never be edited to look cleverer than it was.
In plain words · Kimberly-Clark Corporation, together with its subsidiaries, manufactures and markets personal care products in the United States.
read at $111.44
Kimberly-Clark holds its Markup at $111.44.
- PHPhase · the trend structure carries the Markup label
- INInsiders · no filings inside 60 days, left as found
- POPositioning · no disclosures inside 60 days, left as found
- OPOptions · no verdict drawn today, left as found
- SCScreen · does not pass the values gate
- edge confirmed
- edge broken
- edge forming
Each arm is one independent read. Conviction is not a single call, it is how many edges converge.
The investor read · the season, not the day
| Phase | Markup |
| Quantitative state | Consolidating, no directional conviction, held for 119 days |
| Price | $111.44 |
| Valuation | 21.56 trailing · 14.75 forward price to earnings |
| Values screen | FAIL · score 10.0 |
| Beta | 0.28 |
The opportunity · what the numbers say it is worth
Our framework reads AVOID — it trades at roughly a 19% discount to our $133.07 fair value, moderate competitive moat, 2.70% revenue growth.
Price history & projections · where it has been, where the models see it going
The valuation journey · where the price sits against fair value and the Street
Green marks levels above today's price, red below; the shaded band is the gap between the price and our fair value.
Reading the gap · Our model sees value the Street hasn't fully caught up to yet.
| Revenue growth | 2.70% |
| Profit margin | 12.80% |
| Debt to equity | 371.26 |
| Analyst consensus | Hold · 15 covering |
Fair value and rating are our own model estimates; target range reflects third-party analyst estimates. Analysis, not advice.
The values screen, explained · five checks, plain English
It depends which standard you follow. There are two widely recognised ways to check whether a company is suitable for a Muslim investor, and on this company they disagree. Here is how it did on each:
Used by most halal investing apps ✓ PASSES
The one Titan applies ✗ DOES NOT PASS
Why the two disagree. They fall out over one thing only: the company’s debt. Our stricter standard measures that debt against what the company owns, and it works out too high to pass. The common standard measures the same debt against what the company is worth on the stock market, where it works out low enough to pass. Every other check, the two agree on. So in practice, most halal apps would treat this as fine to hold, while our stricter view would not — and which line you follow is between you and your scholar.
What these two standards are, and how they differ →
- Business activity Its core business isn't built on prohibited lines — no gambling, alcohol, tobacco, weapons, or interest-based lending. Pass
- Debt load Interest-bearing debt is 42.7% of its assets, above the one-third ceiling the screen allows. Against market value it is 19.8%, under the 30% line the market-value standard uses — so that standard clears it. Divergent
- Interest-bearing cash Cash held in interest-bearing accounts and securities is 1.9% of assets, under the one-third limit. Pass
- Receivables Money owed to the company is 14.5% of assets, under the 49% limit. Pass
- Revenue purity Only 0.1% of revenue comes from non-compliant sources — under the 5% line. Pass
Every security is read against two recognised standards: our stricter asset-based screen (ratios measured against total assets) and the more widely used market-value standard (measured against market capitalisation). Where they agree we say so plainly; where they part ways — almost always on the debt check — we show both readings and mark it, because that disagreement is the finding, not a fault. We report the score; you and your scholar make the call.
The business, in plain words · what the numbers mean
Daily Essentials Hide a Heavy Debt Load
Every morning millions reach for the same brands of tissues and nappies without thinking twice. Yet behind those steady sales sits a balance sheet that already fails our ethical screen on debt. At a forward multiple of 14.3 times and revenue growth stuck at 3 percent, the numbers do not justify stepping around that red flag.
We pass for the straightforward reason that high leverage breaks the ethical test, even with a moderate moat, 13 percent profit margins and an eye-catching 112 percent ROE. Fifteen analysts sit on a hold rating with a median target only modestly above the current price, which leaves little margin once the debt burden is weighed properly.
The real risk is that any rise in interest costs or consumer pullback could expose the leverage quickly. Defensive demand helps, but it does not erase the structural problem flagged by the screen. Analysis, not advice.
| Forward P/E | 14.7x expensive even after accounting for its growth |
| Trailing P/E | 21.6x a premium valuation |
| Revenue growth | 2.7% slow but positive growth |
| Profit margin | 12.8% thin but positive margins |
| Return on equity | 111.7% an exceptional return on shareholder capital |
| Debt to equity | 3.71 heavy leverage — higher risk if revenue softens |
| Current ratio | 0.77 below 1 — short-term bills exceed liquid assets |
| Beta | 0.28 barely tracks the market's swings |
| Market cap | $37.0B |
| Employees | 36,000 |
The risks · The things to watch: it carries a real debt load, which raises the stakes if revenue slips.
Plain-English interpretation of our own screen data. Analysis, not advice.
Latest news · what the market is reading on KMB
- › This is Why Kimberly-Clark Corp (KMB) is a Top Dividend Stock to Invest in According to Jim Simons’ Renaissance Technologies Insider Monkey · 16d ago
- › Can Kimberly-Clark's Innovation Strategy Boost Sales Growth? Zacks · 17d ago
- › 4 Dividend Kings Are Crushing the S&P 500 in 2026 and Still Have Big Upside Potential 24/7 Wall St. · 18d ago
- › Is CLX A Value Trap? The Evidence Leans That Way Trefis · 18d ago
- › Church & Dwight vs. Kimberly-Clark: Which Consumer Goods Stock Is a Better Buy in 2026? Motley Fool · 20d ago
Headlines from third-party outlets, linked for reference — not our reporting, not advice.
Related securities · others in KMB's space worth a look
Screened names in the same industry · explore each on its own page.
Where & how to trade · wherever in the world you are
KMB trades on a US exchange. As a US-listed security it is accessible through almost any international broker offering US markets. New to this, or investing from outside the US? Our guide to accessing global markets covers brokers, currencies and the practical steps.
The trader read · the latest dated commentary
The dated journal · newest first, never edited
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns.
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
The insider ledger · Form 4 filings, as filed
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-05-06 | SCRIBNER ANDREW | Officer | 4,095 | $401,310 | |
| 2026-05-04 | CHEN KATY | Officer | 1,596 | $152,164 | |
| 2026-05-01 | URDANETA NELSON | Chief Financial Officer | 6,721 | · | |
| 2026-05-01 | MELUCCI JEFFREY P | Officer | 6,050 | · | |
| 2026-05-01 | TORRES RUSSELL | President | 7,304 | · | |
| 2026-05-01 | HSU MICHAEL D | Chief Executive Officer | 21,612 | · | |
| 2026-05-01 | ABOU-OAF EHAB | Officer | 2,880 | · | |
| 2026-05-01 | FENSKE TAMERA | Officer | 5,462 | · | |
| 2026-05-01 | MCGEE GRANT B | General Counsel | 2,304 | · | |
| 2026-05-01 | CHEN KATY | Officer | 3,456 | · |
Public filings, recorded as found. The full tape lives at Insider Intelligence.
The political ledger · congressional disclosures
| Date | Politician | Party | Type | Amount |
|---|---|---|---|---|
| 2026-04-13 | Ro Khanna | Democrat | Purchase | 1K–15K |
| 15 May2026 | Ro Khanna | Democrat | buy | 1K–15K |
| 1 May2026 | Ro Khanna | Democrat | buy | 1K–15K |
What holding actually paid · price plus dividends
| Period | Price then | Price return | Divs per share | $1,000 became | Total return |
|---|---|---|---|---|---|
| 1 month | $94.45 | +7.8% | $1.28 | $1,092 | +9.2% |
| 2 months | $95.96 | +6.1% | $1.28 | $1,075 | +7.5% |
| 3 months | $96.49 | +5.5% | $1.28 | $1,069 | +6.9% |
| 6 months | $100.80 | +1.0% | $2.56 | $1,036 | +3.6% |
| 1 year | $126.83 | -19.7% | $5.08 | $843 | -15.7% |
| 2 years | $124.66 | -18.3% | $10.04 | $897 | -10.3% |
| 3 years | $119.17 | -14.6% | $14.84 | $979 | -2.1% |
| 5 years | $107.14 | -5.0% | $24.12 | $1,176 | +17.6% |
Historical returns from market close data. Past performance does not guarantee future results.